Cargando…

P715: TOX REGULATED CD8+ T LYMPHOCYTES EXHAUSTED IN MYELODYSPLASTIC SYNDROMES PATIENTS THROUGH ACTIVATING AKT/PI3K/MTOR PATHWAY

Detalles Bibliográficos
Autores principales:	Niu, Haiyue, Zhang, Mengying, Liu, Mengyuan, Shao, Zonghong, Xing, Limin, Wang, Huaquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429676/ http://dx.doi.org/10.1097/01.HS9.0000969764.35373.22

Ejemplares similares

TOX regulates T lymphocytes differentiation and its function in tumor
por: Niu, Haiyue, et al.
Publicado: (2023)

Abnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome
por: Zhang, Gaochao, et al.
Publicado: (2021)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Increased Circulating of CD54(high)CD181(low) Neutrophils in Myelodysplastic Syndrome
por: Yang, Liyan, et al.
Publicado: (2021)

Single-cell RNA sequencing identifies the properties of myelodysplastic syndrome stem cells
por: Liu, Yumei, et al.
Publicado: (2022)

Increased Circulating CD4(+)CXCR5(+) Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases
por: Xiao, Na, et al.
Publicado: (2021)

Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome
por: Han, Yu, et al.
Publicado: (2016)

Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report
por: Niu, Haiyue, et al.
Publicado: (2020)

Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes
por: Jiang, Huijuan, et al.
Publicado: (2018)

Effect of DLK1 on tumorigenesis in CD34(+)CD38(−) bone marrow cells in myelodysplastic syndromes
por: ZHANG, WEI, et al.
Publicado: (2013)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
por: Zhang, Mengying, et al.
Publicado: (2023)

The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria
por: Li, Chenyuan, et al.
Publicado: (2021)

Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
por: Gao, Shan, et al.
Publicado: (2018)

Single-cell RNA sequencing reveals abnormal transcriptome signature of erythroid progenitors in pure red cell aplasia
por: Liu, Yumei, et al.
Publicado: (2023)

Altered follicular helper T cell impaired antibody production in a murine model of myelodysplastic syndromes
por: Jiang, Huijuan, et al.
Publicado: (2017)

Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
por: Zhang, Wei, et al.
Publicado: (2018)

On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens
por: Janesick, Amanda Shaine, et al.
Publicado: (2016)

TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion
por: Khan, Omar, et al.
Publicado: (2019)

Comment on “On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens”
por: Houck, Keith A., et al.
Publicado: (2017)

TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
por: Guo, Longbin, et al.
Publicado: (2020)

Increased TOX expression associates with exhausted T cells in patients with multiple myeloma
por: Zhao, Yujie, et al.
Publicado: (2022)

Reply to “Comment on ‘On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens’”
por: Janesick, Amanda S., et al.
Publicado: (2017)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

Thrombocytosis in 715 Dogs (2011–2015)
por: Woolcock, A.D, et al.
Publicado: (2017)

CD8(+) T cells exhaustion induced by myeloid‐derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal‐9 pathway
por: Tao, Jinglian, et al.
Publicado: (2019)

Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases
por: Chang, Yigang, et al.
Publicado: (2020)

Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)

PI3K/Akt/mTOR inhibitors in breast cancer
por: Lee, Joycelyn JX, et al.
Publicado: (2015)

Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
por: Mickymaray, Suresh, et al.
Publicado: (2021)

Fungal Planet description sheets: 625–715
por: Crous, P.W., et al.
Publicado: (2017)

MON-715 How Heterogeneous Are Pituitary Thyrotropes?
por: Dudley, Lindsey Anne, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia
por: Liu, Yumei, et al.
Publicado: (2022)

Loss of FAM60A attenuates cell proliferation in glioma via suppression of PI3K/Akt/mTOR signaling pathways
por: Liu, Xiaocen, et al.
Publicado: (2021)

TOX as a potential target for immunotherapy in lymphocytic malignancies
por: Liang, Chaofeng, et al.
Publicado: (2021)

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2022)

Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
por: Markman, Ben, et al.
Publicado: (2010)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
por: Matsuoka, Tasuku, et al.
Publicado: (2014)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Targeting the PI3K-AKT-mTOR signaling network in cancer
por: Khan, Khurum H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6cp2jpu3mithf1o34esedpae9k